BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19657206)

  • 1. On: Heusser P, Berger S, Stutz M, Husler A, Haeberli A, Wolf U: efficacy of homeopathically potentized antimony on blood coagulation. Forsch Komplementmed 2009;16:14-18.
    Ernst E
    Forsch Komplementmed; 2009 Jun; 16(3):196; author reply 196. PubMed ID: 19657206
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of homeopathically potentized antimony on blood coagulation. A randomized placebo controlled crossover trial.
    Heusser P; Berger S; Stutz M; Hüsler A; Haeberli A; Wolf U
    Forsch Komplementmed; 2009 Feb; 16(1):14-8. PubMed ID: 19295225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does homeopathically potentized antimony stimulate coagulation? A summary of previous findings and results of an in vitro pilot study by means of thrombelastography.
    Heusser P; Stutz M; Haeberli A
    J Altern Complement Med; 2004 Oct; 10(5):829-34. PubMed ID: 15650472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On: Piltan D, Rist L, Simões-Wüst A, Saller R: Test of a homeopathic dilution of Aconitum napellus. A clinical, randomized, double-blind, controlled crossover study in healthy volunteers. Forsch Komplementmed 2009;16:168-173.
    Thurneysen A
    Forsch Komplementmed; 2009 Oct; 16(5):349. PubMed ID: 19887816
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anticoagulative effect and antiplatelet aggregation effect of combination of Hirudo and Tabanus on rat model of blood stasis syndrome].
    Liang JQ; Mi SQ; Wang NS
    Zhong Yao Cai; 2009 Sep; 32(9):1347-50. PubMed ID: 20034208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the optimal activated clotting times during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials.
    Helft G; Beygui F; le Feuvre C; Metzger JP
    Circulation; 2001 Nov; 104(22):E124. PubMed ID: 11723037
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of highland frogs from the two-legged stage with homeopathically prepared thyroxin (10-11 - 10-21).
    Lingg G; Endler PC; Frass M; Lothaller H
    ScientificWorldJournal; 2008 Apr; 8():446-50. PubMed ID: 18454254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On: Bernateck M, Becker M, Schwake C, Hoy L, Passie T, Parlesak A, Fischer MJ, Fink M, Karst M: Adjuvant auricular electroacupuncture and autogenic training in rheumatoid arthritis: a randomized controlled trial. Forsch Komplementmed 2008;15:187-193.
    Ernst E
    Forsch Komplementmed; 2008 Oct; 15(5):286; author reply 286. PubMed ID: 19009726
    [No Abstract]   [Full Text] [Related]  

  • 9. [A preliminary observation on the pharmacological effect of huoxue zhitong powder].
    Shen DL; Chen WY; Li XY; Gao WX
    Zhongguo Zhong Yao Za Zhi; 1993 Jun; 18(6):364-6, 383. PubMed ID: 8274217
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of anticoagulant activity of ethanol extracts from leech in vitro].
    Feng GJ; Zhu ZG; Yu CL; Zhang Q; Chen NN; Lei LS; Wu SG
    Zhong Yao Cai; 2007 Aug; 30(8):909-11. PubMed ID: 18074833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of terramycin on blood coagulation time].
    BRANCATO U; CUCINOTTI F
    Riv Patol Clin; 1954 Oct; 9(10):437-41. PubMed ID: 13225500
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of ceanothyn on blood coagulation time.
    BISHOP JG; RICHARDSON AW
    J Am Pharm Assoc Am Pharm Assoc; 1957 Jul; 46(7):396-8. PubMed ID: 13491407
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental studies on anticoagulant activity of different extract of leech in vitro].
    Li Y; Huang R; Sun X
    Zhong Yao Cai; 2004 Feb; 27(2):123-5. PubMed ID: 22455002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A preliminary pharmacological study of differently processed leech].
    Lu WH; Ding CH; Wang Q
    Zhongguo Zhong Yao Za Zhi; 1994 Jul; 19(7):407-9, 446. PubMed ID: 7802945
    [No Abstract]   [Full Text] [Related]  

  • 15. [The coagulation parameters in high-dosage intravenous heparin therapy].
    Weidmann B
    Dtsch Med Wochenschr; 1994 Mar; 119(12):442. PubMed ID: 8143564
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-frozen transports of whole blood samples do not cause relevant bias for global coagulation tests in clinical trials evaluating the drug safety.
    Totzke U; Kuyas C
    Contemp Clin Trials; 2005 Aug; 26(4):488-502. PubMed ID: 16054581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated partial thromboplastin time and activated coagulation time in monitoring heparinized cats.
    Greene CE; Meriwether E
    Am J Vet Res; 1982 Aug; 43(8):1473-7. PubMed ID: 7103231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravenous high-dose methylprednisolone on coagulation and fibrinolysis markers.
    Frank RD; Altenwerth B; Brandenburg VM; Nolden-Koch M; Block F
    Thromb Haemost; 2005 Aug; 94(2):467-8. PubMed ID: 16116692
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative efficacy of two microdoses of a potentized homeopathic drug, arsenicum album, to ameliorate toxicity induced by repeated sublethal injections of arsenic trioxide in mice.
    Banerjee P; Bhattacharyya SS; Pathak S; Naoual B; Belon P; Khuda-Bukhsh AR
    Pathobiology; 2008; 75(3):156-70. PubMed ID: 18550913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new plasma-adapted hydroxyethylstarch preparation: in vitro coagulation studies using thrombelastography and whole blood aggregometry.
    Boldt J; Wolf M; Mengistu A
    Anesth Analg; 2007 Feb; 104(2):425-30. PubMed ID: 17242103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.